Related Experiment Video
Updated: Apr 24, 2026

06:44
Isolation of Small Noncoding RNAs from Human Serum
Published on: June 19, 2014
17.7K
Distribution profiling of circulating microRNAs in serum
Jonathan Ashby1, Kenneth Flack, Luis A Jimenez
1Department of Chemistry; ‡Program in Biomedical Sciences; §Department of Statistics, University of California, Riverside , Riverside, California 92521, United States.
Analytical Chemistry
|September 6, 2014
Summary
Analyzing circulating microRNAs (miRNAs) in serum carriers reveals distinct cancer biomarker profiles. This method enhances cancer diagnosis by differentiating miRNA distribution in exosomes and lipoprotein particles.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Circulating microRNAs (miRNAs) are promising cancer biomarkers.
- miRNAs are transported via carriers like proteins, lipoproteins, and exosomes.
- The distribution of miRNAs within these carriers, not just total quantity, may correlate with cancer.
Purpose of the Study:
- To develop a method for separating serum miRNA carriers.
- To analyze miRNA distribution profiles in healthy individuals versus cancer patients.
- To identify specific miRNA carriers as potential cancer biomarkers.
Main Methods:
- Asymmetrical flow field flow fractionation (AF4) was used to separate serum miRNA carriers.
- Six fractions enriched with different carriers (lipoproteins, exosomes) were collected.
- Reverse transcription quantitative polymerase chain reaction (RT-qPCR) quantified eight selected miRNAs in each fraction.
Main Results:
- Fractionated miRNA analysis revealed larger quantity changes between controls and cancer patients compared to total miRNA levels.
- Statistical analysis showed significant differences in 4 miRNAs within specific fractions between groups.
- Principal component analysis demonstrated clear separation between control and cancer groups based on fractionated miRNA amounts.
Conclusions:
- The developed AF4 method effectively screens circulating miRNA distribution in serum carriers.
- Analyzing miRNA distribution profiles enhances the detection of differences between healthy and cancer states.
- This approach facilitates the discovery of specific miRNA biomarkers for improved cancer diagnosis.
Related Concept Videos
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs
20.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
20.8K

